drugset / Trial / NCT00176488
Epirubicin and Vinorelbine in Treating Patients With Stage II, Stage III, or Stage IV Breast Cancer
Phase 2
Terminated
31 enrolled
University of Medicine and Dentistry of New Jersey
National Cancer Institute (NCI) · collab
NaSingle-groupOpen-labelTreatment
Summary
RATIONALE: Drugs used in chemotherapy, such as epirubicin and vinorelbine, work in different ways to stop the growth of tumor cells, either by killing the cells or by stopping them from dividing. Giving epirubicin together with vinorelbine may kill more tumor cells. PURPOSE: This phase II trial is studying how well giving epirubicin together with vinorelbine works in treating patients with stage II, stage III, or stage IV breast cancer.
Timeline
- Start
- 2003-06
- Primary completion
- 2009-10
- Completion
- 2009-10
Outcome
Outcome not reported
Stopped: “Competing studies”
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Epirubicin | Small molecule | 100 mg/m2 | Intravenous |
| Subject | Vinorelbine | Small molecule | 18.75 mg/m2 | Intravenous |